Pancrease Benign Tumors
Pancrease Benign Tumors
Pancrease Benign Tumors
Benign Tumors
Serous Cystadenoma
Serous Cystadenoma
Spongy appearance, microcystic> macrocystic
Thin serous fluid that does not stain positive for
mucin and is low in CEA (<200 ng/mL)
Typical imaging characteristics:
well-circumscribed cystic mass
small septations
fluid close to water density
central scar with calcification
EUS-FNA
Nonviscous fluid with low CEA and amylase levels,
Cells are obtained: cuboidal and have a clear cytoplasm.
Mucinous Cystadenoma
Benign but potentially malignant
carcinoma with a very aggressive behavior
6% to 36% - reported to be malignant
Commonly seen in perimenopausal
women
2/3 are located in the body or tail of the
pancreas.
Incidental finding
Nonspecific symptoms: upper abdominal
discomfort or pain, early satiety, and weight
loss
Mucinous Cystadenoma
Imaging studies
The cysts have thick walls and do not
communicate with the main pancreatic duct
Nodules or calcifications within the wall of the
cyst
Cysts are lined by tall columnar epithelium
that fills the cyst with viscous mucin
Submucosal layer consists of a highly cellular
stroma of spindle cells with elongated nuclei
Elevated CEA levels in the fluid (>200 ng/mL)
may suggest malignant transformation.
Mucinous Cystadenoma
Resection is the treatment of choice: distal pancreatectomy
Malignant transformation more common with
larger tumors
older patients
stepwise accumulation of mutations (K-ras, p53)
Small lesions
preserve the spleen
splenectomy ensures removal of the lymph node basin
Important not to rupture the cyst during resection and the tumor
should be removed intact, not morselized.
Prognosis
Complete resection, without atypia, small (<3cm) cured
Complete resection with moderate dysplasia or CIST- cured
Invasive carcinoma, mucinous cystadenocarcinoma - dismal